Cargando…

CYP2C19 Loss‐of‐function Polymorphisms are Associated with Reduced Risk of Sulfonylurea Treatment Failure in Chinese Patients with Type 2 Diabetes

Sulfonylureas (SUs) are predominantly metabolized by cytochrome p450 2C9 (CYP2C9) and cytochrome p450 2C19 (CYP2C19) enzymes. CYP2C9 polymorphisms are associated with greater treatment response and hypoglycemic risk in SU users. However, there are no large scale pharmacogenetic studies investigating...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Ke, Yang, Aimin, Shi, Mai, Tam, Claudia C. H., Lau, Eric S. H., Fan, Baoqi, Lim, Cadmon K. P., Lee, Heung Man, Kong, Alice P. S., Luk, Andrea O. Y., Tomlinson, Brian, Ma, Ronald C. W., Chan, Juliana C. N., Chow, Elaine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297921/ https://www.ncbi.nlm.nih.gov/pubmed/34656068 http://dx.doi.org/10.1002/cpt.2446

Ejemplares similares

Associations of the HOMA2‐%B and HOMA2‐IR with progression to diabetes and glycaemic deterioration in young and middle‐aged Chinese
por: Fan, Baoqi, et al.
Publicado: (2022)

Risk Associations of Glycemic Burden and Obesity With Liver Cancer—A 10‐Year Analysis of 15,280 Patients With Type 2 Diabetes
por: Mao, Dandan, et al.
Publicado: (2022)

The role of age on the risk relationship between prediabetes and major morbidities and mortality: Analysis of the Hong Kong diabetes surveillance database of 2 million Chinese adults
por: Zhang, Xinge, et al.
Publicado: (2022)

Clinical outcomes following discontinuation of renin-angiotensin-system inhibitors in patients with type 2 diabetes and advanced chronic kidney disease: A prospective cohort study
por: Yang, Aimin, et al.
Publicado: (2022)

Risk associations of long-term HbA1c variability and obesity on cancer events and cancer-specific death in 15,286 patients with diabetes - A prospective cohort study
por: Mao, Dandan, et al.
Publicado: (2021)

Comment on Dawed et al. Genome-Wide Meta-Analysis Identifies Genetic Variants Associated With Glycemic Response to Sulfonylureas. Diabetes Care 2021;44:2673–2682
por: Wang, Ke, et al.
Publicado: (2022)

Differential Associations of GAD Antibodies (GADA) and C-Peptide With Insulin Initiation, Glycemic Responses, and Severe Hypoglycemia in Patients Diagnosed With Type 2 Diabetes
por: Fan, Baoqi, et al.
Publicado: (2023)

Relative leucocyte telomere length is associated with incident end-stage kidney disease and rapid decline of kidney function in type 2 diabetes: analysis from the Hong Kong Diabetes Register
por: Cheng, Feifei, et al.
Publicado: (2021)

Lifetime risk of developing diabetes in Chinese people with normoglycemia or prediabetes: A modeling study
por: Zhang, Xinge, et al.
Publicado: (2022)

Glucose-lowering drug use, glycemic outcomes, and severe hypoglycemia: 18-Year trends in 0·9 million adults with Diabetes in Hong Kong (2002–2019)
por: Yang, Aimin, et al.
Publicado: (2022)

Age- and sex-specific hospital bed-day rates in people with and without type 2 diabetes: A territory-wide population-based cohort study of 1.5 million people in Hong Kong
por: Wu, Hongjiang, et al.
Publicado: (2023)

Age-specific population attributable risk factors for all-cause and cause-specific mortality in type 2 diabetes: An analysis of a 6-year prospective cohort study of over 360,000 people in Hong Kong
por: Wu, Hongjiang, et al.
Publicado: (2023)

Shortened Leukocyte Telomere Length Is Associated With Glycemic Progression in Type 2 Diabetes: A Prospective and Mendelian Randomization Analysis
por: Cheng, Feifei, et al.
Publicado: (2022)

Effects of RAS inhibitors on all-site cancers and mortality in the Hong Kong diabetes surveillance database (2002-2019)
por: Yang, Aimin, et al.
Publicado: (2022)

SAT-134 Association between Serum Branched-Chain Amino Acids and Cancer Risk: The Hong Kong Diabetes Register (HKDR)
por: Lim, Lee Ling, et al.
Publicado: (2019)

Evaluating the impact of glucokinase activation on risk of cardiovascular disease: a Mendelian randomisation analysis
por: Wang, Ke, et al.
Publicado: (2022)

Dorzagliatin, a Dual-Acting Glucokinase Activator, Increases Insulin Secretion and Glucose Sensitivity in Glucokinase Maturity-Onset Diabetes of the Young and Recent-Onset Type 2 Diabetes
por: Chow, Elaine, et al.
Publicado: (2023)

Detection of increased serum miR-122-5p and miR-455-3p levels before the clinical diagnosis of liver cancer in people with type 2 diabetes
por: Lee, Heung Man, et al.
Publicado: (2021)

Attenuated Risk Association of End-Stage Kidney Disease with Metformin in Type 2 Diabetes with eGFR Categories 1–4
por: Yang, Aimin, et al.
Publicado: (2022)

Trends in diabetes-related complications in Hong Kong, 2001–2016: a retrospective cohort study
por: Wu, Hongjiang, et al.
Publicado: (2020)

Incident cardiovascular-kidney disease, diabetic ketoacidosis, hypoglycaemia and mortality in adult-onset type 1 diabetes: a population-based retrospective cohort study in Hong Kong
por: Fan, Yingnan, et al.
Publicado: (2023)

CYP2C19*2 Polymorphism Is Associated with Impaired Oral Clearance of Gliclazide in Healthy Chinese
por: Chow, Elaine, et al.
Publicado: (2019)

High-density lipoprotein subclasses and cardiovascular disease and mortality in type 2 diabetes: analysis from the Hong Kong Diabetes Biobank
por: Jin, Qiao, et al.
Publicado: (2022)

Temporal trends in rates of infection-related hospitalisations in Hong Kong people with and without diabetes, 2001–2016: a retrospective study
por: Luk, Andrea O. Y., et al.
Publicado: (2020)

Secular trends in incidence of type 1 and type 2 diabetes in Hong Kong: A retrospective cohort study
por: Luk, Andrea O. Y., et al.
Publicado: (2020)

Trends in kidney failure and kidney replacement therapy in people with diabetes in Hong Kong, 2002-2015: A retrospective cohort study
por: Wu, Hongjiang, et al.
Publicado: (2021)

Age at diagnosis, glycemic trajectories, and responses to oral glucose-lowering drugs in type 2 diabetes in Hong Kong: A population-based observational study
por: Ke, Calvin, et al.
Publicado: (2020)

Glycemic Variability and Time in Range During Self-titration of Once Daily Insulin Glargine 300 U/ml Versus Neutral Protamine Hagedorn Insulin in Insulin-naïve Chinese Type 2 Diabetes Patients
por: Ling, James, et al.
Publicado: (2021)

Development of genome-wide polygenic risk scores for lipid traits and clinical applications for dyslipidemia, subclinical atherosclerosis, and diabetes cardiovascular complications among East Asians
por: Tam, Claudia H. T., et al.
Publicado: (2021)

Development and validation of algorithms to classify type 1 and 2 diabetes according to age at diagnosis using electronic health records
por: Ke, Calvin, et al.
Publicado: (2020)

The Effect of CYP2C9 Genotype Variants in Type 2 Diabetes on the Pharmacological Effectiveness of Sulfonylureas, Diabetic Retinopathy, and Nephropathy
por: Saberi, Meisam, et al.
Publicado: (2020)

Identification of a Common Variant for Coronary Heart Disease at PDE1A Contributes to Individualized Treatment Goals and Risk Stratification of Cardiovascular Complications in Chinese Patients With Type 2 Diabetes
por: Tam, Claudia H.T., et al.
Publicado: (2023)

Influence of CYP2D6 and CYP3A5 Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Bisoprolol in Hypertensive Chinese Patients
por: Chan, Sze Wa, et al.
Publicado: (2021)

Obesity, clinical, and genetic predictors for glycemic progression in Chinese patients with type 2 diabetes: A cohort study using the Hong Kong Diabetes Register and Hong Kong Diabetes Biobank
por: Jiang, Guozhi, et al.
Publicado: (2020)

Consensus Recommendations on Sulfonylurea and Sulfonylurea Combinations in the Management of Type 2 Diabetes Mellitus – International Task Force
por: Kalra, Sanjay, et al.
Publicado: (2018)

Sulfonylurea: Personalized Medicine for Type 2 Diabetes
por: Hwang, You-Cheol
Publicado: (2015)

Sulfonylurea use and the risk of hospital readmission in patients with type 2 diabetes
por: Heaton, Pamela C., et al.
Publicado: (2016)

Interaction between variants in the CYP2C9 and POR genes and the risk of sulfonylurea‐induced hypoglycaemia: A GoDARTS Study
por: Dujic, Tanja, et al.
Publicado: (2017)

Commentary on “Consensus Recommendations on Sulfonylurea and Sulfonylurea Combinations in the Management of Type 2 Diabetes Mellitus: International Task Force”
por: Singh, S. K.
Publicado: (2018)

Development of Osteoarthritis in Adults With Type 2 Diabetes Treated With Metformin vs a Sulfonylurea
por: Baker, Matthew C., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rsfruj5tjd9lccbo3tosa96kng